THREE International has announced that its metabolic health supplement GLP THREE™ is now officially listed in the Prescriber’s Digital Reference (PDR).
This addition increases the total number of THREE International products listed in the database to seven wellness products and two personal care products. The milestone reflects the company’s continued commitment to product transparency, quality verification, and science-based formulation.
The Prescriber’s Digital Reference is widely used by healthcare professionals. It provides standardized information about ingredients, safety data, and formulation details.
Unlike promotional product directories, the Prescriber’s Digital Reference (PDR) serves as a clinical information platform. It is commonly used by physicians, pharmacists, and healthcare professionals.
The database allows professionals to review:
This listing enables healthcare professionals to review GLP THREE™ in a trusted clinical environment. It also supports transparency in product information and development standards.
According to the PDR entry, GLP THREE™ contains 320 mg of GLP THREE Complex. This formula is built around the company’s proprietary Metabolic Boost Complex-267 (MBC-267™).
The formulation includes a combination of bioactive and botanical ingredients such as:
Research referenced in the listing suggests that natural molecules in GLP THREE™ may help support the GLP-1 metabolic pathway, which plays a role in metabolic health.
The supplement is delivered using proprietary cellular absorption technology. This system is designed to support effective nutrient delivery and uptake.
Dr. Dan Gubler, Chief Scientific Officer at THREE International, described the listing as a significant milestone.
He stated that inclusion in the Prescriber’s Digital Reference supports the scientific credibility of the company’s formulations. It also ensures that healthcare professionals can access accurate product data in a standardized format.
Company leadership believes this recognition reflects the strength of its research-backed approach to product development.
THREE International reports that all of its products undergo third-party laboratory testing. These tests help verify:
Independent laboratories also screen for heavy metals, contaminants, and ingredient authenticity. This process helps ensure that the contents of each product match its label.
The growing number of listings in the PDR database reflects the company’s dedication to maintaining strict quality control standards.
Company leaders noted that expanding its presence in the Prescriber’s Digital Reference supports long-term trust with healthcare professionals.
By maintaining transparent product documentation and verified ingredient information, the company aims to strengthen its position within the nutritional supplement industry.
Healthcare professionals can access complete details about GLP THREE™ directly through the Prescriber’s Digital Reference platform.
Statements related to GLP THREE™ have not been evaluated by the U.S. Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.
THREE International develops nutritional supplements designed to support metabolic health, weight management, and overall wellness.
The company focuses on:
THREE International distributes its products globally through independent distributors and customers. Its mission centers on delivering trusted wellness solutions supported by scientific research.
There are no reviews yet. Be the first one to write one.
